X-84105840-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014496.5(RPS6KA6):āc.1402A>Gā(p.Ile468Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000306 in 1,176,182 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.000032 ( 0 hom. 13 hem. )
Consequence
RPS6KA6
NM_014496.5 missense
NM_014496.5 missense
Scores
1
3
13
Clinical Significance
Conservation
PhyloP100: 7.84
Genes affected
RPS6KA6 (HGNC:10435): (ribosomal protein S6 kinase A6) This gene encodes a member of ribosomal S6 kinase family, serine-threonine protein kinases which are regulated by growth factors. The encoded protein may be distinct from other members of this family, however, as studies suggest it is not growth factor dependent and may not participate in the same signaling pathways. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.22287479).
BS2
High Hemizygotes in GnomAdExome4 at 13 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPS6KA6 | NM_014496.5 | c.1402A>G | p.Ile468Val | missense_variant | 16/22 | ENST00000262752.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPS6KA6 | ENST00000262752.5 | c.1402A>G | p.Ile468Val | missense_variant | 16/22 | 1 | NM_014496.5 | P1 | |
RPS6KA6 | ENST00000620340.4 | c.1402A>G | p.Ile468Val | missense_variant | 16/22 | 5 | |||
RPS6KA6 | ENST00000495332.1 | n.134A>G | non_coding_transcript_exon_variant | 2/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111220Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33530
GnomAD3 genomes
AF:
AC:
2
AN:
111220
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33530
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000574 AC: 10AN: 174290Hom.: 0 AF XY: 0.0000837 AC XY: 5AN XY: 59736
GnomAD3 exomes
AF:
AC:
10
AN:
174290
Hom.:
AF XY:
AC XY:
5
AN XY:
59736
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000319 AC: 34AN: 1064962Hom.: 0 Cov.: 23 AF XY: 0.0000388 AC XY: 13AN XY: 335134
GnomAD4 exome
AF:
AC:
34
AN:
1064962
Hom.:
Cov.:
23
AF XY:
AC XY:
13
AN XY:
335134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111220Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33530
GnomAD4 genome
AF:
AC:
2
AN:
111220
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33530
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.1402A>G (p.I468V) alteration is located in exon 16 (coding exon 16) of the RPS6KA6 gene. This alteration results from a A to G substitution at nucleotide position 1402, causing the isoleucine (I) at amino acid position 468 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;T
Sift4G
Benign
T;T
Polyphen
0.0040
.;B
Vest4
MVP
MPC
0.45
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at